In order to gain a full understanding of common mental health and behavioral disorders we must understand both the molecular underpinnings of the problem as well as the social factors that contribute to it.
The mission of the Center for Molecular and Behavioral Neuroscience is to conduct research in all phases—basic, translational, clinical, social, and behavioral—that will generate new knowledge and perhaps reduce health disparities in neurological disease and mental health.
The Center is connecting independent researchers from various disciplines of study, allowing dynamic face-time for budding researchers in their rotations and summer internships. They are being exposed to cutting-edge research: the Center’s neuro-scientific approach is an advanced method for engaging in such work.
Director, Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience
Interim Vice President for Research and Innovation, Professor
Meharry Medical College
Center for Women's Health Research, Health Disparities Research Center of Excellence, Center for Molecular & Behavioral Neuroscience
Assistant Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience
Director, Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience
Associate Professor
School of Medicine
Center for AIDS Health Disparities Research, Center for Molecular & Behavioral Neuroscience
Associate Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience
Professor
School of Dentistry
Center for Women's Health Research, Data Science Institute, Health Disparities Research Center of Excellence, Center for Molecular & Behavioral Neuroscience
Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience
Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure.
Jones B, Balasubramaniam M, Lebowitz JJ, Taylor A, Villalta F, Khoshbouei H, Grueter C, Grueter B, Dash C, Pandhare J
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
Patel JD, Lee JW, Carbone DP, Wagner H, Shanker A, de Aquino MTP, Horn L, Johnson ML, Gerber DE, Liu JJ, Das MS, Al-Nsour MA, Dakhil CSR, Ramalingam S, Schiller JH
Porphyromonas gingivalis infection alters Nrf2-Phase II enzymes and nitric oxide in primary human aortic endothelial cells.
Sampath C, Okoro EU, Gipson MJ, Chukkapalli SS, Farmer-Dixon CM, Gangula PR
Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
Sampath C, Srinivasan S, Freeman ML, Gangula PR